Eva Garland Consulting (EGC) is an Inc. 5000 fastest growing consulting firm that supports innovators in accessing billions of dollars in government grants and contracts.
Trending
EGC Opens New Office in California
Eva Garland Consulting (EGC) is pleased to announce the opening of their newest office on the West Coast. Located in Irvine, California, at the Cove @ UCI, this expansion reinforces EGC’s commitment to supporting technology innovators and broadens the firm’s rapidly growing presence across the U.S.
EGC Newsletter
EGC’s October newsletter announces the grand opening of our new location in Irvine, California, celebrates the success of our client, Xmark Labs, and showcases exciting new funding opportunities from ARPA-H and the DOE, as well the NIH and CDMRP.
EGC Expands to New Office Space in Raleigh to Support Growing Accounting Team
EGC, a leading provider of comprehensive accounting and financial services for high-growth technology companies, is pleased to announce the expansion of their office space in Raleigh, North Carolina. The firm has secured an additional 3,000 square feet of space to accommodate EGC's rapidly growing Accounting, Compliance & Financial Advisory team.
EGC Launches WINS Program for Women Entrepreneurs Pursuing NSF Funding
In a continued commitment to support female entrepreneurs, EGC has been awarded a second $50,000 prize from the U.S. Small Business Administration for Stage Two of the Growth Accelerator Fund Competition. Building on the success of Stage One, this funding will enable EGC to launch the WINS (Women In NSF SBIR) program. WINS is specifically designed to enhance access to SBIR/STTR funding for women-led startups pursuing National Science Foundation grants that foster innovative technologies with commercial potential. Applications for the WINS program are open now, offering a unique opportunity for women entrepreneurs to advance their ventures.
National Cancer Institute (NCI) Announces EGC as Leader of SBIR/STTR Entrepreneurship and Training Program (STEP)
STEP is designed to empower participants with the skills and resources needed to secure funding, advance their projects, and bring groundbreaking innovations to market—all aimed at enhancing cancer treatment and prevention. By fostering collaboration between academia and industry, STEP aims to accelerate the development of promising technologies.
Recent News
November 7, 2024
EGC Opens New Office in California
Eva Garland Consulting (EGC) is pleased to announce the opening of their newest office on the West Coast. Located in Irvine, California, this…
October 24, 2024
EGC Expands Headquarters with New Office Space in Raleigh to Support Growing Accounting Team
Eva Garland Consulting (EGC) is pleased to announce the expansion of its headquarters in Raleigh with a new office space in the Bank of America Tower…
October 7, 2024
Eva Garland Consulting Awarded Contract to Lead the National Cancer Institute’s SBIR/STTR Program
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
October 1, 2024
EGC Wins 2024 Growth Accelerator Fund Competition Stage Two
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
September 24, 2024
Government Accounting & Legal Compliance Webinar Series: Intellectual Property Overview
This webinar provided a nuts-and-bolts overview of legal frameworks designed to protect your ideas and valuable business information, with insights…
September 12, 2024
Grants Expert Dr. Connie Vance Featured in Golden Age of Technology Newsletter
EGC Scientific Consultant Connie Vance, Ph.D. featured in an interview with Sarah Richard for the Golden Age of Technology newsletter.
September 12, 2024
Fall 2024 Grant Webinar Series
Eva Garland Consulting (EGC) is pleased to present a three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued commitment to…
August 29, 2024
Fall 2024 Grant Webinar Series | Harvesting America’s Seed Fund: Guidance for Navigating the NSF’s SBIR / STTR Application Process
Eva Garland Consulting (EGC) is pleased to announce a new three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued…
Recent News
November 7, 2024
EGC Opens New Office in California
Eva Garland Consulting (EGC) is pleased to announce the opening of their newest office on the West Coast. Located in Irvine, California, this…
October 24, 2024
EGC Expands Headquarters with New Office Space in Raleigh to Support Growing Accounting Team
Eva Garland Consulting (EGC) is pleased to announce the expansion of its headquarters in Raleigh with a new office space in the Bank of America Tower…
October 7, 2024
Eva Garland Consulting Awarded Contract to Lead the National Cancer Institute’s SBIR/STTR Program
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
October 1, 2024
EGC Wins 2024 Growth Accelerator Fund Competition Stage Two
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA),…
September 24, 2024
Government Accounting & Legal Compliance Webinar Series: Intellectual Property Overview
This webinar provided a nuts-and-bolts overview of legal frameworks designed to protect your ideas and valuable business information, with insights…
September 12, 2024
Grants Expert Dr. Connie Vance Featured in Golden Age of Technology Newsletter
EGC Scientific Consultant Connie Vance, Ph.D. featured in an interview with Sarah Richard for the Golden Age of Technology newsletter.
September 12, 2024
Fall 2024 Grant Webinar Series
Eva Garland Consulting (EGC) is pleased to present a three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued commitment to…
August 29, 2024
Fall 2024 Grant Webinar Series | Harvesting America’s Seed Fund: Guidance for Navigating the NSF’s SBIR / STTR Application Process
Eva Garland Consulting (EGC) is pleased to announce a new three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued…
Client Highlights
Boston Metal
By partnership with EGC, Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Partnering with EGC, Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Ascent Integrated Tech developed a system to monitor firefighters' health and environment, securing over $2.8 million in funding.
AgroSpheres
With EGC's support, AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
With EGC's assistance, FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences has leveraged EGC's partnership to secure over $2.5 million in NIH funding, driving advancements in probiotic treatments for conditions like necrotizing enterocolitis and autism, and attracting a $26.5 million Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Boston Metal
By partnership with EGC, Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Partnering with EGC, Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Ascent Integrated Tech developed a system to monitor firefighters' health and environment, securing over $2.8 million in funding.
AgroSpheres
With EGC's support, AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
With EGC's assistance, FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences has leveraged EGC's partnership to secure over $2.5 million in NIH funding, driving advancements in probiotic treatments for conditions like necrotizing enterocolitis and autism, and attracting a $26.5 million Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Our Clients Have Secured
$1,991,689,721
In Non-dilutive Funding
“We consider Eva Garland, an essential partner in our strategy for obtaining non-dilutive funding from a variety of sources, including the NIH.”
Cuthbert Simpkins, MD
“My EGC consultants participate heavily in the scientific writing rather than just managing submissions for completeness. They are knowledgeable about the best practices to make grants most attractive to reviewers.”
Jeremy Elser, Ph.D. CEO
“The knowledgeable, friendly and professional team that we worked with to set up our strategic plan turned the chaos of federal grants into a clear roadmap.”
Wendy Morgan, CEO
“We love everyone and everything EGC! Thank you for incredible support.”
Zachary G. Forbes, Ph.D., President & CEO
“I have recommended Eva Garland to four other businesses since first meeting you guys in 2021 and will continue to do so for years to come. Thanks!”
Alli Truttmann, Founder and CEO
“The EGC team has been an integral part of our fundraising strategy for several years.”
Jean Peccoud, CEO
“I have worked with Eva Garland over multiple grant applications and always had a stellar experience. Not only do they help as general writers but also perform great research and ask the hard questions required to make our applications really stand out.”
Grant Chapman, CEO
“We have peace of mind knowing all of our questions will be answered and we are receiving the highest quality feedback in a super responsive manner.”
Amir Helmy, CEO
“We consider Eva Garland, an essential partner in our strategy for obtaining non-dilutive funding from a variety of sources, including the NIH.”
Cuthbert Simpkins, MD
“My EGC consultants participate heavily in the scientific writing rather than just managing submissions for completeness. They are knowledgeable about the best practices to make grants most attractive to reviewers.”
Jeremy Elser, Ph.D. CEO
“The knowledgeable, friendly and professional team that we worked with to set up our strategic plan turned the chaos of federal grants into a clear roadmap.”
Wendy Morgan, CEO
“We love everyone and everything EGC! Thank you for incredible support.”
Zachary G. Forbes, Ph.D., President & CEO
“I have recommended Eva Garland to four other businesses since first meeting you guys in 2021 and will continue to do so for years to come. Thanks!”
Alli Truttmann, Founder and CEO
“The EGC team has been an integral part of our fundraising strategy for several years.”
Jean Peccoud, CEO
“I have worked with Eva Garland over multiple grant applications and always had a stellar experience. Not only do they help as general writers but also perform great research and ask the hard questions required to make our applications really stand out.”
Grant Chapman, CEO
“We have peace of mind knowing all of our questions will be answered and we are receiving the highest quality feedback in a super responsive manner.”